[{"Assets_0_Q3_USD":150143000.0,"CommonStockSharesOutstanding_0_Q3_shares":28558653.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-23978000.0,"NetIncomeLoss_1_Q3_USD":-15554000.0,"NetIncomeLoss_3_Q3_USD":-28144000.0,"StockholdersEquity_0_Q3_USD":143384000.0,"Ticker":"AKRO","CIK":"1744659","name":"AKERO THERAPEUTICS, INC.","OfficialName":"Akero Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"399847718.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]